SGMO
Sangamo Therapeutics, Inc.
A biotechnology company that makes genomic medicines using zinc finger proteins—natural human proteins engineered to bind specific DNA sequences, enabling gene therapy and genome editing for serious diseases. Founded in 1995 by Edward Lanphier, its name was inspired by the Sangamon River in Illinois, borrowed from the earlier Sangamo Electric Company that Lanphier's relatives helped found a century earlier.
CUSIP: 800677106HealthcareUS1 holder1 derivative reporter
Total Value
$1.83M
Total Shares
200.0K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
